These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 25740294)
1. Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study. Pieterse C; Schutte R; Schutte AE Hypertens Res; 2015 Jul; 38(7):507-12. PubMed ID: 25740294 [TBL] [Abstract][Full Text] [Related]
2. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. De Pergola G; De Mitrio V; Giorgino F; Sciaraffia M; Minenna A; Di Bari L; Pannacciulli N; Giorgino R Int J Obes Relat Metab Disord; 1997 Jul; 21(7):527-535. PubMed ID: 9226481 [TBL] [Abstract][Full Text] [Related]
3. Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin? Mertens I; Considine RV; Van der Planken M; Van Gaal LF Eur J Endocrinol; 2006 Sep; 155(3):477-84. PubMed ID: 16914603 [TBL] [Abstract][Full Text] [Related]
4. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Sudi KM; Gallistl S; Weinhandl G; Muntean W; Borkenstein MH Metabolism; 2000 Jul; 49(7):890-5. PubMed ID: 10910001 [TBL] [Abstract][Full Text] [Related]
5. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women? Mertens I; Van der Planken M; Corthouts B; Van Gaal LF Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442 [TBL] [Abstract][Full Text] [Related]
6. Leukocyte telomere length and hemostatic factors in a South African cohort: the SABPA Study. von Känel R; Malan NT; Hamer M; van der Westhuizen FH; Malan L J Thromb Haemost; 2014 Dec; 12(12):1975-85. PubMed ID: 25244563 [TBL] [Abstract][Full Text] [Related]
7. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896 [TBL] [Abstract][Full Text] [Related]
8. The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults. Eksteen P; Pieters M; de Lange Z; Kruger HS Thromb Res; 2015 Aug; 136(2):415-21. PubMed ID: 26070447 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with early platelet activation in obese children. Gómez García A; Núñez GG; Sandoval ME; Castellanos SG; Alvarez Aguilar C Clin Med Res; 2014 Sep; 12(1-2):21-6. PubMed ID: 24415745 [TBL] [Abstract][Full Text] [Related]
10. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance. Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701 [TBL] [Abstract][Full Text] [Related]
11. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Mertens I; Verrijken A; Michiels JJ; Van der Planken M; Ruige JB; Van Gaal LF Int J Obes (Lond); 2006 Aug; 30(8):1308-14. PubMed ID: 16389265 [TBL] [Abstract][Full Text] [Related]
12. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity. Mantovani RM; Rios DR; Moura LC; Oliveira JM; Carvalho FF; Cunha SB; Viana Mde F; Lamounier JA; Castro JC; Dusse LM; Simões e Silva AC J Pediatr Endocrinol Metab; 2011; 24(5-6):361-7. PubMed ID: 21823537 [TBL] [Abstract][Full Text] [Related]
13. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men]. Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251 [TBL] [Abstract][Full Text] [Related]
14. Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin. Gómez-Ambrosi J; Salvador J; Silva C; Pastor C; Rotellar F; Gil MJ; Cienfuegos JA; Frühbeck G Thromb Haemost; 2006 Jun; 95(6):991-6. PubMed ID: 16732378 [TBL] [Abstract][Full Text] [Related]
16. Relationship between high plasma leptin concentrations and metabolic syndrome in obese pre-pubertal children. Valle M; Gascón F; Martos R; Bermudo F; Ceballos P; Suanes A Int J Obes Relat Metab Disord; 2003 Jan; 27(1):13-8. PubMed ID: 12532148 [TBL] [Abstract][Full Text] [Related]
17. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194 [TBL] [Abstract][Full Text] [Related]
18. Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Morel O; Luca F; Grunebaum L; Jesel L; Meyer N; Desprez D; Robert S; Dignat-George F; Toti F; Simon C; Goichot B Int J Obes (Lond); 2011 Dec; 35(12):1479-86. PubMed ID: 21386797 [TBL] [Abstract][Full Text] [Related]
19. PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes. Mertens I; Lemieux I; Verrijken A; Després JP; Van Gaal LF Diabetes Metab Res Rev; 2008 Feb; 24(2):141-7. PubMed ID: 17922472 [TBL] [Abstract][Full Text] [Related]
20. Is albuminuria associated with obesity in school children? Hirschler V; Molinari C; Maccallini G; Aranda C Pediatr Diabetes; 2010 Aug; 11(5):322-30. PubMed ID: 19968814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]